Arkolith/Insider Trading/ACRV/Form 4

Levy Adam D.

Chief Financial OfficerAcrivon Therapeutics, Inc. (ACRV) · full profile →Form 4 · filed Jan 16, 2026
Net Buying
Open-Market Buys
$15K
Open-Market Sells
$0
Net Open-Market Flow
$15K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 14, 2026Buy(P)9K$1.70$15K21K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-26-000225) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML